326 related articles for article (PubMed ID: 19417147)
1. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.
LeBeau AM; Brennen WN; Aggarwal S; Denmeade SR
Mol Cancer Ther; 2009 May; 8(5):1378-86. PubMed ID: 19417147
[TBL] [Abstract][Full Text] [Related]
2. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.
Brennen WN; Rosen DM; Wang H; Isaacs JT; Denmeade SR
J Natl Cancer Inst; 2012 Sep; 104(17):1320-34. PubMed ID: 22911669
[TBL] [Abstract][Full Text] [Related]
3. Selective Activation of Anticancer Chemotherapy by Cancer-Associated Fibroblasts in the Tumor Microenvironment.
Kim MG; Shon Y; Kim J; Oh YK
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27615014
[TBL] [Abstract][Full Text] [Related]
4. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions.
Huang Y; Simms AE; Mazur A; Wang S; León NR; Jones B; Aziz N; Kelly T
Clin Exp Metastasis; 2011 Aug; 28(6):567-79. PubMed ID: 21604185
[TBL] [Abstract][Full Text] [Related]
6. Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments.
Christiansen VJ; Jackson KW; Lee KN; Downs TD; McKee PA
Neoplasia; 2013 Apr; 15(4):348-58. PubMed ID: 23555181
[TBL] [Abstract][Full Text] [Related]
7. [FIBROBLAST ACTIVATION PROTEIN (FAP) AS A POSSIBLE TARGET OF THE ANTITUMOR STRATEGY.].
Pleshkan VV; Alekseenko IV; Tyulkina DV; Kyzmich AI; Zinovyeva MV; Sverdlov ED
Mol Gen Mikrobiol Virusol; 2016; 34(3):90-97. PubMed ID: 30383930
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells.
Lai D; Ma L; Wang F
Int J Oncol; 2012 Aug; 41(2):541-50. PubMed ID: 22614695
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?
Juillerat-Jeanneret L; Tafelmeyer P; Golshayan D
Expert Opin Ther Targets; 2017 Oct; 21(10):977-991. PubMed ID: 28829211
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.
Scanlan MJ; Raj BK; Calvo B; Garin-Chesa P; Sanz-Moncasi MP; Healey JH; Old LJ; Rettig WJ
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5657-61. PubMed ID: 7911242
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A
Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
Kakarla S; Chow KK; Mata M; Shaffer DR; Song XT; Wu MF; Liu H; Wang LL; Rowley DR; Pfizenmaier K; Gottschalk S
Mol Ther; 2013 Aug; 21(8):1611-20. PubMed ID: 23732988
[TBL] [Abstract][Full Text] [Related]
13. Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase.
Jackson KW; Christiansen VJ; Yadav VR; Silasi-Mansat R; Lupu F; Awasthi V; Zhang RR; McKee PA
Neoplasia; 2015 Jan; 17(1):43-54. PubMed ID: 25622898
[TBL] [Abstract][Full Text] [Related]
14. Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics.
Zhang HE; Hamson EJ; Koczorowska MM; Tholen S; Chowdhury S; Bailey CG; Lay AJ; Twigg SM; Lee Q; Roediger B; Biniossek ML; O'Rourke MB; McCaughan GW; Keane FM; Schilling O; Gorrell MD
Mol Cell Proteomics; 2019 Jan; 18(1):65-85. PubMed ID: 30257879
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and toxicology of a fibroblast activation protein (FAP)-activated prodrug in murine xenograft models of human cancer.
Brennen WN; Rosen DM; Chaux A; Netto GJ; Isaacs JT; Denmeade SR
Prostate; 2014 Sep; 74(13):1308-19. PubMed ID: 25053236
[TBL] [Abstract][Full Text] [Related]
16. A rare variant in human fibroblast activation protein associated with ER stress, loss of enzymatic function and loss of cell surface localisation.
Osborne B; Yao TW; Wang XM; Chen Y; Kotan LD; Nadvi NA; Herdem M; McCaughan GW; Allen JD; Yu DM; Topaloglu AK; Gorrell MD
Biochim Biophys Acta; 2014 Jul; 1844(7):1248-59. PubMed ID: 24717288
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.
Teichgräber V; Monasterio C; Chaitanya K; Boger R; Gordon K; Dieterle T; Jäger D; Bauer S
Adv Med Sci; 2015 Sep; 60(2):264-72. PubMed ID: 26057860
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
19. Targeting fibroblast activation protein in cancer - Prospects and caveats.
Busek P; Mateu R; Zubal M; Kotackova L; Sedo A
Front Biosci (Landmark Ed); 2018 Jun; 23(10):1933-1968. PubMed ID: 29772538
[TBL] [Abstract][Full Text] [Related]
20. Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma:
Watabe T; Liu Y; Kaneda-Nakashima K; Shirakami Y; Lindner T; Ooe K; Toyoshima A; Nagata K; Shimosegawa E; Haberkorn U; Kratochwil C; Shinohara A; Giesel F; Hatazawa J
J Nucl Med; 2020 Apr; 61(4):563-569. PubMed ID: 31586001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
